Skip to main content
  • Editorial: Pushing TAVR Beyond the Boundaries of a Surgery-Capable Center: Malpractice or a Rescue Plan?

    A study by Joseph et al. in this issue of the journal examined the safety and efficiency of redeploying a transcatheter aortic valve replacement (TAVR) service during the COVID-19 pandemic [1]. Given the strain on the healthcare system and restriction of services during this contemporary and unprecedented crisis, the authors undertook a pilot study to evaluate the feasibility of a TAVR service streamlined in less than a week to address urgent and emergent cases of severe and symptomatic aortic stenosis. An experienced team was, therefore, moved from a tertiary surgical center with a high COVID-19 admission burden to a hospital with no previous experience in percutaneous valve intervention nor an intensive care unit (ICU) or on-site cardiac surgery.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details